ATE184793T1 - Die verwendung von carbostyrilderivaten zur herstellung eines arzneimittels zur hemmung der produktion von interleukin-8 - Google Patents

Die verwendung von carbostyrilderivaten zur herstellung eines arzneimittels zur hemmung der produktion von interleukin-8

Info

Publication number
ATE184793T1
ATE184793T1 AT94929670T AT94929670T ATE184793T1 AT E184793 T1 ATE184793 T1 AT E184793T1 AT 94929670 T AT94929670 T AT 94929670T AT 94929670 T AT94929670 T AT 94929670T AT E184793 T1 ATE184793 T1 AT E184793T1
Authority
AT
Austria
Prior art keywords
interleukin
pct
production
inhibiting
inhibit
Prior art date
Application number
AT94929670T
Other languages
English (en)
Inventor
Takahide Matsuda
Shigeru Owada
Hiroshi Muta
Miki Aihara
Hisao Takizawa
Ken-Ichi Imagawa
Mikio Kikuchi
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Application granted granted Critical
Publication of ATE184793T1 publication Critical patent/ATE184793T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
AT94929670T 1993-10-21 1994-10-17 Die verwendung von carbostyrilderivaten zur herstellung eines arzneimittels zur hemmung der produktion von interleukin-8 ATE184793T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP26341993 1993-10-21
JP26341793 1993-10-21
JP26341893 1993-10-21
JP8964194 1994-04-27

Publications (1)

Publication Number Publication Date
ATE184793T1 true ATE184793T1 (de) 1999-10-15

Family

ID=27467652

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94929670T ATE184793T1 (de) 1993-10-21 1994-10-17 Die verwendung von carbostyrilderivaten zur herstellung eines arzneimittels zur hemmung der produktion von interleukin-8

Country Status (14)

Country Link
US (1) US5637597A (de)
EP (1) EP0674515B1 (de)
JP (1) JP2839847B2 (de)
KR (1) KR100191191B1 (de)
CN (1) CN1073418C (de)
AT (1) ATE184793T1 (de)
AU (1) AU683697B2 (de)
CA (1) CA2150546C (de)
DE (1) DE69420832T2 (de)
DK (1) DK0674515T3 (de)
ES (1) ES2138092T3 (de)
GR (1) GR3032091T3 (de)
TW (1) TW296983B (de)
WO (1) WO1995011026A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR004214A1 (es) * 1995-10-12 1998-11-04 Otsuka Pharma Co Ltd Una preparación de gotas oftálmicas para la cura de enfermedades oftálmicas
DE10029404B4 (de) * 2000-06-15 2009-10-29 Jagotec Ag Arzneiformulierung enthaltend Ciclosporin und deren Verwendung
FR2812548B1 (fr) * 2000-08-01 2002-09-20 Sanofi Synthelabo Utilisation de derives de quinolein-2(1h)-one ou un de leurs sels pharmaceutiquement acceptable pour la preparation d'un medicament destine au traitement de l'insuffisance renale
US7408078B2 (en) * 2002-10-08 2008-08-05 Wyeth Anthranilic acid derivatives useful in treating infection with hepatitis C virus
EP1648563B1 (de) 2003-07-30 2007-09-19 Otsuka Pharmaceutical Co., Ltd. Carbostyril-derivative zur beschleunigten speichelabsonderung
TWI340650B (en) * 2004-01-21 2011-04-21 Otsuka Pharma Co Ltd Amine saly of carbostyril derivative
MY149159A (en) 2005-11-15 2013-07-31 Hoffmann La Roche Method for treating joint damage
WO2009022674A1 (en) * 2007-08-10 2009-02-19 Otsuka Pharmaceutical Co., Ltd. Medical composition containing rebamipide
KR101104634B1 (ko) * 2009-08-25 2012-01-12 한림제약(주) 레바미피드를 포함하는 류마티스 관절염 예방 또는 치료용 약학 조성물
KR101182114B1 (ko) * 2010-03-05 2012-09-12 한림제약(주) 유효성분으로서 레바미피드를 함유하는 골관절염 예방 또는 치료용 약학 조성물
WO2012114317A1 (en) 2011-02-25 2012-08-30 Nuformix Limited Novel rebamipide complexes and cocrystals
KR20140020289A (ko) 2011-03-24 2014-02-18 오츠카 세이야쿠 가부시키가이샤 레바미피드를 함유하는 구강 내 질환 치료용 의약 조성물
JP6294773B2 (ja) * 2014-06-27 2018-03-14 株式会社ナールスコーポレーション 口腔粘膜疾患の予防または治療用経口製剤
WO2022128054A1 (en) 2020-12-14 2022-06-23 Symrise Ag Medicament for fighting inflammatory conditions of human skin (iv)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4578381A (en) * 1982-07-05 1986-03-25 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
GB8334494D0 (en) * 1983-12-24 1984-02-01 Tanabe Seiyaku Co Carbostyril derivatives
JPS63119467A (ja) * 1987-10-21 1988-05-24 Otsuka Pharmaceut Co Ltd カルボスチリル誘導体
JPH02178227A (ja) * 1988-12-28 1990-07-11 Otsuka Pharmaceut Co Ltd 腎炎治療剤
JP2812998B2 (ja) * 1989-08-14 1998-10-22 大塚製薬 株式会社 胃炎治療剤
KR0180248B1 (ko) * 1991-06-07 1999-03-20 오오쓰까 아끼히꼬 항당뇨병약품
CA2090876A1 (en) * 1991-07-03 1993-01-04 Satoru Nakai Apoptosis regulating composition
TW227558B (de) * 1992-05-14 1994-08-01 Otsuka Pharma Co Ltd
JP2872546B2 (ja) * 1992-11-26 1999-03-17 大塚製薬株式会社 腸粘膜障害保護剤
WO1994014444A1 (en) * 1992-12-24 1994-07-07 Otsuka Pharmaceutical Co., Ltd. Psoriasis remedy
WO1994020107A1 (en) * 1993-03-02 1994-09-15 Otsuka Pharmaceutical Co., Ltd. Rejection inhibitor for transplants and il-1 production inhibitor

Also Published As

Publication number Publication date
WO1995011026A1 (en) 1995-04-27
CN1073418C (zh) 2001-10-24
GR3032091T3 (en) 2000-03-31
EP0674515A1 (de) 1995-10-04
KR950703957A (ko) 1995-11-17
TW296983B (de) 1997-02-01
DE69420832T2 (de) 2000-01-13
KR100191191B1 (ko) 1999-06-15
US5637597A (en) 1997-06-10
CA2150546A1 (en) 1995-04-27
EP0674515B1 (de) 1999-09-22
AU683697B2 (en) 1997-11-20
CA2150546C (en) 2004-11-09
ES2138092T3 (es) 2000-01-01
AU7864194A (en) 1995-05-08
JP2839847B2 (ja) 1998-12-16
DE69420832D1 (de) 1999-10-28
JPH0812578A (ja) 1996-01-16
CN1117268A (zh) 1996-02-21
DK0674515T3 (da) 1999-12-20

Similar Documents

Publication Publication Date Title
ES2102195T3 (es) Derivados heterociclicos de acido carbonico que se fijan en receptores de retinoides.
ATE184793T1 (de) Die verwendung von carbostyrilderivaten zur herstellung eines arzneimittels zur hemmung der produktion von interleukin-8
DE69723869D1 (de) Heterozyklische verbindungen, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen die diese enthalten und ihre anwendung in der behandlung von diabetis und verwandten krankheiten
HUP9600448A2 (hu) Naftilvegyületek, e vegyületeket tartalmazó gyógyszerkészítmények, eljárás előállításukra, intermedierjeik és alkalmazásuk
FI941022A (fi) Spirosykliset piperidiinijohdannaiset
ES2124424T3 (es) Azadioxacicloalquenos substituidos y su empleo como fungicidas.
DE69521424T2 (de) Benzofuran derivate und ihre verwendung als inhibitoren der knochenresorption
DK0696281T3 (da) Hidtil ukendte 5-pyrrolyl-2-pyridylmethylsulfinylbenzimidazolderivater
DE3767839D1 (de) Pyrrolidinamid-derivate mit antipropylendopeptidase-wirkung, zusammenstellungen, die sie enthalten, verfahren zu ihrer herstellung und heilmittel, die sie enthalten.
ATE217616T1 (de) Tetrasubstituierte imidazolderivate, verfahren zu ihrer herstellung, ihre anwendung als medikamente und diese enthaltende pharmazeutischen zusammensetzungen
ATE157871T1 (de) Arzneimittel zur therapeutischen und prophylaktischen behandlung von krankheiten, die durch hyperplasie der glatten muskelzellen bedingt sind
ATE233246T1 (de) Hydantoinderivate als zwischenprodukte für pharmazeutische wirkstoffe
DE69227583T2 (de) Arylmorpholine, herstellung und verwendung
BR9408244A (pt) Derivados de azabiciclo[3.2.0]heptano N-substituídos
ATE345787T1 (de) Verwendung von cyclohexenon derivaten zur herstellung eines medikaments für die behandlung von dysurie
HK1025506A1 (en) Pharmaceutical products for curing and preventing diseases resulting from the damaging of the vascular endothelial cells
ES2128313T3 (es) Naftalimidas n-substituidas, su obtencion y empleo.
DE69606777D1 (de) Naphthamidderivate von 3-beta-amino azabicyclooctan oder nonan als antipsychotische arzneimittel
YU17999A (sh) Novi derivati pentaeritrita, njihova izrada i primena kao i međuproizvodi za njihovu sintezu
DE59606725D1 (de) Substituierte phenylamidine, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE69406451T2 (de) Verfahren zur herstellung von n-carbonylarylimine als zwischenprodukte in der synthese von therapeutisch aktiven taxol-derivaten
RU94045839A (ru) Производные 3-(фенилалкиламиноалкилокси)-5-фенилпиразола, а также способ и промежуточные вещества для их получения, лекарственное средство, содержащее эти соединения
ATE186640T1 (de) Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung neurogenerativer erkrankungen
EE03488B1 (et) Meetod anhüdroekgoniini estrite valmistamiseks
DE59106666D1 (de) Bicyclo [3.3.0]octan-derivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification